The CRISPR system provides adaptive immunity against mobile genetic elements in prokaryotes, using small CRISPR RNAs that direct effector complexes to degrade invading nucleic acids 1-3 . Type III effector complexes were recently demonstrated to synthesize a novel second messenger, cyclic oligoadenylate, on binding target RNA 4,5 . Cyclic oligoadenylate, in turn, binds to and activates ribonucleases and other factors-via a CRISPR-associated Rossmanfold domain-and thereby induces in the cell an antiviral state that is important for immunity. The mechanism of the 'off-switch' that resets the system is not understood. Here we identify the nuclease that degrades these cyclic oligoadenylate ring molecules. This 'ring nuclease' is itself a protein of the CRISPR-associated Rossman-fold family, and has a metal-independent mechanism that cleaves cyclic tetraadenylate rings to generate linear diadenylate species and switches off the antiviral state. The identification of ring nucleases adds an important insight to the CRISPR system. Cyclic oligoadenylate (cOA; with a ring size of 4 (tetraadenylate, cA 4 ) or 6 (hexaadenylate, cA 6 ) AMP monomers) has emerged as a key second messenger that signals the presence of invading mobile genetic elements in prokaryotes that contain type III (Csm or Cmr) CRISPR systems 4,5 . cOA is synthesized by the cyclase domain of the Cas10 subunit, which is activated by the binding of target RNA. cOA, in turn, activates a range of proteins with CRISPR-associated Rossmanfold (CARF) domains including 'higher eukaryotes and prokaryotes nucleotide binding' (HEPN)-domain ribonucleases (Csm6 and Csx1) and transcription factors 6-8 , which precipitates an antiviral state in infected cells that may enhance viral clearance, result in dormancy or result in cell death 9 . There are interesting parallels with the cGAS-cGAMP-STING pathway in eukaryotes, in which detection of DNA in the cytoplasm leads to synthesis of a cyclic nucleotide that activates the host immune response 10 . The HEPN ribonucleases are important for CRISPR-based immunity in vivo [11] [12] [13] . cOA is therefore a potent signalling molecule that must be tightly controlled if cells are to survive a viral infection. cOA synthesis is switched off when type III effectors cleave and release viral RNA targets 5,14 . However, this will not remove extant cOA, which could potentially lead to untrammelled RNase activity and cell death. Other cyclic nucleotide signalling molecules in prokaryotes, such as di-cAMP, are degraded by specific phosphodiesterases 15,16 , but the enzyme specific for cOA is unknown. Here we report the identification and characterization of a family of enzymes that degrade cA 4 , providing a mechanism for the deactivation of the antiviral state induced by cA 4 in cells that contain a type III CRISPR system.
| Purification and identification of the enzyme that degrades cA 4 . a-c, S. solfataricus cell lysate was fractionated by phenyl-sepharose (a), size-exclusion (b) and heparin (c) chromatography. At each stage, fractions were assayed for cA 4 conversion activity using radioactive cA 4 , and active fractions that generated product X (indicated by shaded boxes) were pooled for the next stage. d, Following the heparin column, each fraction was assayed and analysed by SDS-PAGE. The band corresponding to the peak of activity (arrowed) was excised from the gel and identified by mass spectrometry as Sso2081, a CARF-domain protein. e, Purified recombinant Sso2081 and Sso 1393 degrade cA 4 , but Csx1 does not. f, Only Csx1 degrades linear RNA in the presence of cA 4 . Panels a-f are representative of experiments performed at least in duplicate. c, control without protein; mAU, milli-absorbance units; m, protein markers; fr, fractions. Letter reSeArCH protein family 17 . To confirm that Sso2081 was the nuclease responsible for degradation of cA 4 , we expressed and purified the recombinant protein in Escherichia coli. The enzyme converted cA 4 to a slowermigrating species on gel electrophoresis, as seen for the activity from S. solfataricus, in a reaction independent of divalent metal ions (Fig. 1e ). We also noted that the Csx1 nuclease (Sso1389; RCSB Protein Data Bank (PDB) code: 2I71) 14 is found close to an uncharacterized CARFdomain protein of known structure (Sso1393) that is homologous to Sso2081 (Extended Data Figs. 1, 2) . Pure recombinant Sso1393 also exhibits cA 4 -degradation activity, whereas Csx1 does not (Fig. 1e ). By contrast, of the three enzymes only Csx1 displays cA 4 -stimulated RNase activity on a linear RNA substrate (Fig. 1f ). Sso2081 and Sso1393 degrade cA 4 with single-turnover rate constants of 0.23 ± 0.01 and 0.024 ± 0.0004 min −1 , respectively ( Fig. 2a and Extended Data Fig. 3 ). The tenfold-higher specific activity of Sso2081, combined with the higher expression levels of this protein in S. solfataricus 18 , suggest that it is the major cA 4 -degrading enzyme in this organism.
Metal-independent ribonucleases and ribozymes-including the Cas6 nuclease family 19 -share a common mechanism: activation of the 2′-hydroxyl of the ribose sugar as the nucleophile that attacks the phosphodiester bond targeted for cleavage, which leads to products with a 2′,3′-cyclic phosphate and a 5′-hydroxyl moiety 20 . To determine the degradation products of cA 4 treated with Sso2081 and Sso1393, we analysed radioactively labelled species by thin-layer chromatography ( Fig. 2b and Extended Data Fig. 4 ). Sso2081 converted cA 4 into a distinct species (product X) that could be phosphorylated by treatment with polynucleotide kinase, which shows that product X is a linear product with a 5′-OH group (Fig. 2b, lanes 2, 3) . For Sso1393, a linear intermediate product (product Y) with a 5′-OH group that converted over time into the final product (product X) was also observed (Fig. 2b, lanes 4-7) . Lanes 8 and 9 in Fig. 2b show standards that were generated by cleavage of RNA oligonucleotides by the MazF RNase 14 , to generate the species 5′-phospho-diadenylate with a cyclic 2′,3′ phosphate (P-A 2 >P, in which '>P' denotes the cyclic phosphate) and 5′-phospho-tetraadenylate (P-A 4 >P), respectively. Once the final products of Sso2081 and 1393 are phosphorylated by polynucleotide kinase, they run at the same position as the P-A 2 >P standard, whereas the intermediate (product Y) that was observed for Sso1393 runs at the same position as the P-A 4 >P standard after a similar treatment with polynucleotide kinase.
To identify the products X and Y, we incubated Sso2081 and 1393 individually with cA 4 and analysed the reaction products by liquid chromatography coupled with high-resolution mass spectrometry (LC-HRMS, Fig. 2c, d) . After a 60-min incubation with recombinant Sso2081, the peak corresponding to cA 4 had almost completely disappeared in favour of the main product X with a retention time of 4.4 min, alongside a trace of product Y that eluted at 11.9 min ( Fig. 2c and Extended Data Fig. 5 ). Linear A 2 and A 4 species with a 2′,3′-cyclic phosphate-generated using the MazF toxin 14 -eluted with retention times that were comparable to those of products X and Y, respectively. Mass spectrometry revealed product X to have a neutral mass of 658.104 atomic mass units (amu), consistent with linear A 2 >P. The mass of product Y (1,316.208 amu), on the other hand, was consistent with A 4 >P. The same products were observed for Sso1393 ( Fig. 2d and Extended Data Fig. 6 ). Again, A 2 >P (product X) was the main product and A 4 >P (product Y) was more visible at early time points, consistent with the slower catalytic rate of Sso1393. Thus, these enzymes break the cA 4 ring using a metal-independent mechanism, which generates a linear A 4 The active site residues K168 and S11 are shown. b, Kinetic analysis of Sso1393 (wild type (WT), and S11A and K168A variants) and Sso2081 (wild type, and S11A and R105A, K106A variants). Catalytic rate constants under single-turnover conditions are plotted. The data points are derived from exponential fits to the triplicate rate measurements presented in Extended Data Fig. 8 , with the standard errors derived from curve fitting shown. c, Cartoon showing the reaction scheme for conversion of cyclic to linear A 4 >P and A 2 >P. S11 may participate in the correct positioning of the 2′-OH group of the ribose to facilitate nucleophilic attack, and the basic residue K168 (and R105 and K106 in Sso2081) may stabilize the pentacovalent phosphorus formed in the transition state.
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2′,3′-cyclic phosphate termini. We tested the specific activity of Sso2081 against available cyclic nucleotide molecules-cA 6 , cA 4 , cyclic di-AMP, cyclic di-GMP and cyclic GMP-AMP (Extended Data Fig. 7 )-and confirmed that the enzyme is highly specific for the degradation of cA 4 , and has a very low level of activity directed against cA 6 and no detectable degradation of the cyclic dinucleotides. We propose that this family of phosphodiesterases be known collectively as ring nucleases. The structure of Sso1393 (PDB: 3QYF) reveals a canonical CARF domain formed by a homodimeric subunit arrangement, with a C-terminal extension. To elucidate the mechanism of ring nucleases, we docked cA 4 into the CARF domain of Sso1393 ( Fig. 3a and Extended Data Fig. 8 ). This simple model without energy minimization allows hypotheses concerning the enzyme mechanism to be drawn. Using structure-guided multiple sequence alignment of Sso1393, Sso2081 and homologues (Extended Data Fig. 2 ), we identified conserved residues that are positioned close to the cA 4 -binding site that might have a role in catalysis ( Fig. 3 ). We noted the conservation of a lysine (K168 in Sso1393) that is predicted to lie in the centre of the cA 4 binding site, which could have a role in catalysis. Sso2081 has two basic residues (R105 and K106) in this position. Sso1393(K168A) was catalytically inactive, as was the Sso2081(R105A, K106A) variant, which confirms that these residues have an important role in catalysis-possibly by stabilizing the pentacovalent phosphorous generated in the transition state 20 (Fig. 3b and Extended Data Fig. 8 ). The conserved residue S11 is also implicated in catalysis: the catalytic rate constant was reduced by 3.5-and 32-fold for Sso2081(S11A) and Sso1393(S11A), respectively ( Fig. 3b and Extended Data Fig. 8 ). Consistent with the absence of ring nuclease activity, Csx1 lacks these key active-site residues.
Based on the evidence available, we propose that cleavage of cA 4 is catalysed by binding the molecule in an orientation that enables the 2′-hydroxyl of the ribose to attack the bridging phosphorus, coupled with stabilization of the developing transition state by the basic residue(s) at the base of the binding pocket (Fig. 3c ). The single-turnover rate constant for Sso2081 is below 1 min −1 , which is comparable to the Cas6 nuclease family (which uses a similar mechanism 19, 21 ) . Given the dimeric organization of the CARF domain, there is the possibility for two active sites to act on opposite sides of the cA 4 ring, consistent with the observation of an A 2 >P product. For the slower Sso1393 enzyme, appreciable levels of A 4 >P intermediate were observed, which suggests that the two active sites need not function in a concerted manner.
We next wished to reconstitute the cA 4 signalling system in vitro to confirm the function of the ring nucleases. We first tested the ability of ring nucleases to deactivate Csx1, observing that as cA 4 is converted to A 2 >P the activation of the Csx1 HEPN RNase is abrogated (Extended Data Fig. 9 ). We then set up a reaction containing the Csm effector complex, 0.5 mM ATP and a variable concentration of target RNA (from 10 to 0.01 nM), to activate cA 4 synthesis. After incubation for 1 h at 70 °C in the presence or absence of 2.5 μM Sso2081, 0.5 μM Csx1 and radioactively labelled substrate RNA were added. Transcript levels of the sso2081 gene are about twofold higher than those of the csx1 gene in uninfected S. solfataricus cells 18 , and large changes in expression of these genes were not observed on infection with the STIV virus 22 . Target RNA binding by Csm activates the cyclase domain, which switches on cA 4 production. The cyclase domain is deactivated when target RNA is cleaved and dissociates from Csm, leaving the complex free to bind to further targets 14 . Higher concentrations of target RNA thus result in higher levels of cA 4 and stronger activation of Csx1, which degrades a labelled substrate RNA (Fig. 4a ). The presence of Sso2081 abrogated the activation of Csx1 in a manner that was dependent on the concentration of target RNA. This recapitulates the situation that is likely to prevail in cells infected with a virus, in which viral RNA load determines the extent of cOA production and speed of subsequent clearance by the ring nuclease ( Fig. 4b) .
Thus, we have identified a family of ring nucleases containing CARF domains as the enzymes responsible for the degradation of cA 4 , which is synthesized by type III CRISPR systems in response to the detection of viral RNA. The ring nucleases act as the off-switch for the system, limiting the damage that is caused by the HEPN ribonucleasesactivated by cA 4 -once invading RNA has been cleared from the cell. The relatively slow kinetics of cA 4 degradation by ring nucleases are probably consistent with the requirement to maintain the antiviral response for an appropriate period, but we cannot rule out the possibility that other factors increase the cA 4 clearance rate under certain circumstances. Clearly, it will be important to follow up these biochemical studies with genetic analyses to elucidate the function of ring nucleases in the antiviral cOA-signalling pathway in vivo.
Many type III CRISPR systems have multiple associated proteins containing a CARF-domain; some of these proteins may be specialized for the degradation of cOA. Ring nucleases are hard to identify using bioinformatics analysis, as they involve the 'grafting' of a minimal RNase catalytic site onto an extensive cOA binding site in the CARF domain. In a minimal system, it is possible that a single enzyme has a C-terminal HEPN-family RNase coupled to an N-terminal CARFfamily ring nuclease. This would allow cOA binding to rapidly switch Letter reSeArCH on RNase activity and then slowly auto-deactivate by cOA cleavage. However, specialization of CARF proteins as ring nucleases would yield the advantage of enabling levels of cOA-activated RNase and cOAdegrading ring nuclease activity to be controlled independently. It is also possible that cA 6 rings-such as those generated in Streptococcus thermophilus-will be processed differently, as they are likely to have more conformational flexibility than cA 4 . The recent identification of a wide range of as-yet-uncharacterized CARF-domain proteins across the prokaryotes 8 suggests that we have only scratched the surface of this system. These are fruitful areas for future studies.
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MEthodS
No statistical methods were used to predetermine sample size. The experiments were not randomized and investigators were not blinded to allocation during experiments and outcome assessment. Purification of cA 4 -degrading enzyme from S. solfataricus cellular extract. S. solfataricus (Sso) P2 was grown as previously described 23 and cells pelleted by centrifugation at 4,000 r.p.m. (Beckman Coulter Avanti JXN-26; JLA8.1 rotor) for 15 min at 4 °C. Cells were suspended in buffer A containing 100 mM sodium phosphate pH 7.0 and 1.5 M ammonium sulfate with one EDTA-free protease inhibitor tablet (Roche). Cells were lysed by sonicating six times for 1 min with 1 min rest intervals on ice, and the lysate was ultracentrifuged at 40,000 r.p.m. (Beckman Coulter Optima L-90K; 70 Ti rotor) and 4 °C for 45 min before filtering and loading onto a phenyl-sepharose column (GE Healthcare) pre-equilibrated with buffer A. Protein was eluted with a linear gradient of buffer B containing 100 mM sodium phosphate pH 7.0 across 10 column volumes (CV). Each fraction was assayed for cA 4 -degradation activity and fractions displaying cA 4 degradation were pooled and concentrated using a 10-kDa molecular weight cut-off ultracentrifugal concentrator (Amicon Millipore). Concentrated protein was then further separated by size-exclusion chromatography (S200; 26/60 GE Healthcare) in buffer containing 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) (HEPES) pH 7.5 and 150 mM KCl. Fractions were assayed for cA 4 degradation, and active fractions pooled and concentrated as previously, exchanging into 10 mM 2-(N-morpholino)ethanesulfonic acid (MES) pH 6.0 buffer during concentration. Concentrated protein was then loaded on to a 5-ml HiTrap heparin column (GE Healthcare) equilibrated with 10 mM MES pH 6.0 buffer, washing unbound protein with 8% buffer C containing 10 mM MES pH 6.0 and 1.0 M NaCl for 2 CV. Protein was eluted by a linear gradient to 30% buffer C across 5 CV followed by a gradient to 100% buffer C across 4 CV. After assaying for cA 4 degradation, fractions of interest were visualized by SDS-PAGE. A protein band of ~18 kDa-the presence and abundance of which corresponded to a peak in cA 4 degradation-was excised, trypsin-digested and identified by mass spectrometry. Cloning, expression and purification of Sso2081, Sso1393 and variants. The cloning, expression and purification of Sso1389 (Csx1) has previously been described 14 . A synthetic gene encoding Sso2081 was purchased from Integrated DNA Technologies (IDT), while sso1393 was PCR amplified from S. solfataricus P2 genomic DNA. Genes encoding Sso2081 and Sso1393 were cloned into the pEHisTEV vector 24 , and transformed into E. coli DH5α competent cells. Sso2081(S11A), Sso2081(R105A, K106A), Sso1393(S11A) and Sso1393(K168A) variants were generated by site-directed mutagenesis using the QuickChange Site-Directed Mutagenesis protocol (Agilent Technologies), with DNA primers purchased from IDT. Sequence-verified constructs were transformed into C43 (DE3) E. coli cells for protein expression.
Expression of recombinant Sso2081 and variants was induced with 0.4 mM isopropyl β-d-1-thiogalactopyranoside at an optical density at 600 nm (OD 600 ) of ~0.8, and cells incubated at 16 °C overnight with shaking at 180 r.p.m., before collecting by centrifugation at 4,000 r.p.m. (JLA8.1 rotor) at 4 °C for 15 min. Cells were suspended in lysis buffer (50 mM Tris-HCl pH 8.0, 0.5 M NaCl, 10 mM imidazole and 10% glycerol) with 1 mg ml −1 chicken egg lysozyme (Sigma-Aldrich) and one EDTA-free protease inhibitor tablet. Cells were sonicated six times for 1 min with 1 min rest intervals on ice at 4 °C. Cell lysate was then ultracentrifuged at 40,000 r.p.m. (70 Ti rotor) for 45 min at 4 °C, filtered and loaded onto a 5-ml HisTrap FF column (GE Healthcare) equilibrated with buffer D containing 50 mM Tris-HCl pH 8.0, 0.5 M NaCl, 30 mM imidazole and 10% glycerol. After washing unbound protein with 20 CV buffer D, recombinant Sso2081 and mutants were eluted with a linear gradient (0-20%) of buffer D supplemented with 0.5 M imidazole across 15 CV, then holding at 20% for 4 CV. Pooled fractions were concentrated as previously described, and the hexa-histidine affinity tag was removed by incubating protein with tobacco etch virus (TEV) protease (10:1) for 4 h at 37 °C. His-tag-cleaved Sso2081 was isolated from TEV by affinity chromatography as detailed above, eluting with buffer D before further purification by size-exclusion chromatography (S200 26/60; GE Healthcare) in buffer containing 20 mM Tris-HCl pH 8.0, 0.5 M NaCl and 1 mM dithiothreitol (DTT).
Expression of recombinant Sso1393 (wild type and variants) was induced as above, except cells were grown at 16 °C overnight before collection. Cells were lysed and proteins were purified as for Sso2081. All proteins were aliquoted, flash-frozen with liquid nitrogen, and stored at −80 °C. cA 4 nuclease assays and kinetic analysis. 32 P-α-ATP incorporated cA 4 was generated using the Csm complex as previously described 14 . In brief, the Csm complex was incubated for 2 h at 70 °C in 100 μl final reaction volume in a pH 5.5 buffer containing 20 mM MES, 100 mM potassium glutamate and 1 mM DTT supplemented with 2 mM MgCl 2 , 1 mM ATP, 3 nM 32 P-α-ATP and 100 nM A26 target RNA: (5′-AGGGUCGUUGUUAAGAACGACGUUGUUAGAA GUUGGGUAUGGUGGAGA). The reaction was stopped by phenol-chloroform extraction followed by chloroform extraction. Sso1393, Sso2081 and their mutants were assayed for labelled cA 4 degradation by incubating 2 μM protein dimer with 1/300-diluted, Csm-generated, 32 P-labelled cA 4 (0.33 μl per 100 μl reaction) in buffer E (20 mM 2-amino-2-(hydroxymethyl)-1,3-propanediol pH 8.0, 100 mM NaCl, 1 mM EDTA and 1 mM DTT) at 70 °C. At desired time points, a 10-μl aliquot was removed, and the reaction quenched by adding to chilled phenol-chloroform (Ambion). Subsequently, 5 μl of deproteinized reaction product was extracted into 5 μl 100% formamide for denaturing PAGE. Control reactions include cA 4 incubated in buffer E without protein at 4 °C and at 60 °C up to the end point of each experiment (typically 20, 120 or 180 min), phenol-chloroform extracted as above.
All experiments were carried out in triplicate. cA 4 degradation was visualized by phosphorimaging following denaturing PAGE (7 M Urea, 20% acrylamide, 1× TBE). For kinetic analysis, cA 4 cleavage was quantified using the Bio-Formats plugin 25 of ImageJ 26 as distributed in the Fiji package 27 and fitted to a single exponential curve using Kaleidagraph (Synergy Software), as previously described 28 . HEPN nuclease deactivation assays. For degradation of cA 4 , Csm-generated cA 4 was incubated with 2 μM Sso2081 dimer or 4 μM Sso1393 dimer in buffer E for 60 min and 120 min, respectively. Subsequently, the reaction was deproteinized by phenol-chloroform extraction and diluted twofold in RNase free water. As a control reaction, cA 4 was mock-treated in buffer with water in place of protein and deproteinized as before. Csx1 dimer (500 nM) was incubated with 50 nM A1 RNA and either no cA 4 activator, 1/100-diluted untreated Csm cA 4 , 1/100 mocktreated cA 4 or 1/100 ring-nuclease-treated cA 4 in buffer containing 20 mM MES pH 5.5, 100 mM K-glutamate and 1 mM DTT for 60 min at 70 °C. Reactions were quenched by the addition of a reaction volume equivalent of 100% formamide, and RNA cleavage was assessed by phosphorimaging following denaturing PAGE. Reconstitution of the cA 4 signalling pathway. The Csm complex (70 nM carrying the CRISPR RNA targeting A26) was incubated for 1 h at 70 °C in presence of 2.5 μM of Sso2081 dimer and various concentrations of target A26 single-strand RNA (ssRNA) in a reaction containing 20 mM MES pH 6.0, 100 mM NaCl, 1 mg ml −1 BSA, 2 mM MgCl 2 , 0.5 mM ATP and a 5′-labelled A1 ssRNA that is not recognized by the Csm complex ( 5′-AGGGUAUUAUUUGUUUGUUUCUUCUAAACUA UAAGCUAGUUCUGGAGA). After 1 h incubation, 500 nM of Csx1 dimer was added to the reaction for a further 20 min. Reactions were quenched by deproteination with phenol-chloroform extraction and run on a 20% acrylamide 7 M urea denaturing gel before phosphorimaging to visualize A1 RNA cleavage. The same experiment was carried out in the presence of 3 pM 32 P-α-ATP and unlabelled A1 RNA to visualize the formation and degradation of cA 4 , and 1 μl of the reaction was run on thin-layer chromatography (TLC) before phosphorimaging. Generation of standards using the MazF nuclease. The E. coli toxin-antitoxin MazEF was purified as previously described 14 . Active MazF was liberated either by trypsin (Promega) digestion (1,600:1) at 37 °C for 15 min or by incubation with Factor X Activated (0.1 unit per 1 mg of protein; Sigma-Aldrich) in FXa buffer containing 10 mM Tris-HCl pH 8.0 and 1 mM DTT. For generating linear oligoadenylates A2>P (5′ hydroxyl-ApAp with a 2′,3′-cyclic phosphate) and A4>P, 30 μM A2 (AAACAUCAG) or A4 (AAAAACAUCAG) RNA was incubated with MazF in FXa buffer for 1 h at 37 °C. RNA was deproteinized by phenol-chloroform extraction followed by chloroform extraction. For use as standards, A 2 >P and A 4 >P linear oligoadenylates were 5′-end labelled using 32 P-γ-ATP and T4 polynucleotide kinase (PNK; Thermo Fisher Scientific) via its forward reaction. Thin-layer chromatography. Experiments were performed using silica gel on a 20 × 20 cm TLC plate (Supelco Sigma-Aldrich) containing a fluorescent indicator, allowing visualization of non-radioactive products by ultraviolet (UV) shadowing. Before loading, all samples were deproteinized by phenol-chloroform followed by chloroform extraction. Non-radioactive or radioactive samples (from 0.1 μl to 2 μl) were loaded 1 cm above the bottom of the TLC plate. The TLC plate was then placed in a sealed glass chamber pre-warmed at 30 °C and containing 0.5 cm of a running buffer composed of H 2 O (30%), ethanol (70%) and ammonium bicarbonate (0.2 M), pH 9.3. The buffer was allowed to rise along the plate through capillary action until the migration front reached 15 cm. The plate was dried and radioactive sample migration visualized by phosphorimaging while non-radioactive sample migration was pictured under UV light (254 nm). LC-HRMS. LC-HRMS analysis was performed on a Thermo Scientific Velos Pro instrument equipped with HESI source and Dionex UltiMate 3000 chromatography system. Samples were deproteinized as described for TLC. Compounds were separated on a Kinetex 2.6-μm EVO C18 column (2.1 × 100 mm, Phenomenex) using a linear gradient of acetonitrile (B) against 20 mM ammonium bicarbonate (A): 0-5 min 2% B, 5-33 min 2-15% B, 33-35 min 15-98% B, 35-40 min 98% B, 40-41 min 98-2% B, 41-45 min 2% B. The flow rate was 350 μl min −1 and the column temperature was 40 °C. UV data were recorded at 254 nm. Mass data were acquired on the FT mass analyser in negative-ion mode with scan range m/z 150-1,500 at a resolution of 30,000. Source voltage was set to 3.5 kV, capillary temperature was 350 °C, and source heater temperature was 250 °C. Data were analysed using Xcalibur (Thermo Scientific). Extracted ion chromatograms were smoothed using the Boxcar function at default settings. 
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Extended Data Fig. 7 | Specificity of Sso2081 for cyclic nucleotide substrates. Various cyclic di-and oligonucleotides were incubated in the absence ('ctrl') or presence of Sso2081 as described in Methods. Dinucleotides and cA 6 were obtained from BIOLOG Life Science Institute (Bremen), and cA 4 was obtained from an enzymatic reaction with S. solfataricus Csm. Protein-free extracts were analysed by LC-HRMS essentially as for Fig. 2 , but using a shorter column and gradient.
Extracted-ion chromatograms for substrate and expected products are shown in each panel. No reaction was observed for any of the cyclic dinucleotides. cA 4 was completely converted to linear A 2 >P by Sso2081, whereas only a small percentage of cA 6 was converted. This demonstrates a clear preference of Sso2081 for its physiological substrate, cA 4 . The data presented are representative of experiments performed in duplicate.
Extended Data Fig. 9 | Ring nucleases abrogate activation of the Csx1 nuclease by converting cA 4 to A 2 >P. a, In the absence of cA 4 , Csx1 had no RNase activity (lane 'c'), but addition of cA 4 resulted in degradation of the substrate RNA molecule. When cA 4 was pre-incubated for 1 h at 70 °C with Sso2081 in buffer E before addition to the assay, Csx1 RNase activity was abolished. Mock treatment using buffer instead of Sso2081 (denoted '*') had no effect. b, As for a, but pre-incubated with Sso1393 for 2 h at 70 °C. c, Using radioactive cA 4 , the deactivation of Csx1 by Sso2081 and Sso1393 was observed to correlate with the conversion of cA 4 into A 2 >P. Results shown are representative of experiments performed in at least triplicate.
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Data collection
For Mass Spectrometry, data were collected using Xcalibur (Thermo Fisher, ver 3.1). Phosphorimaging and fluorescence imaging data were collected using Typhoon FLA7000 control software, GE Healthcare.
Data analysis
To quantify phosphorimages, we used the Bio-Formats plugin of ImageJ as distributed in the Fiji package (open source, version 2.0.0) . Kaleidagraph (Synergy Software, ver 4.5) was used to fit reaction data to exponential progress curves. For Mass Spectrometry, data were analysed using Xcalibur (Thermo Fisher, ver 3.1) For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
